XPO Logistics $794 million follow-on and secondary offering
We advised the underwriters on the SEC-registered stock offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
GH Research $184 million IPO
We advised GH Research on the IPO and Nasdaq Listing
Energizer Gamma Acquisition €650 million notes offering
We advised the initial purchasers on the high-yield notes offering
Cyteir Therapeutics $133.2 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Molecular Partners $64 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Ayala Pharmaceuticals $20 million at-the-market offering
We advised the sales agent on the stock offering
UiPath $1.54 billion IPO
The shares are listed on the New York Stock Exchange
Akoya Biosciences $151.3 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Beam Therapeutics $300 million at-the-market offering
We advised the sales agent in connection with the equity offering
LAVA Therapeutics $100.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing